Menü
sharewise zieht um Am Wochenende vom 22./23. August wird das neue sharewise die Hauptseite. Schau es dir jetzt an und sag uns, was dir fehlt. Zum neuen sharewise Was sich ändert
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

Should You Buy Capri Holdings as Value Clashes With Turnaround Risk?
Should You Buy Capri Holdings as Value Clashes With Turnaround Risk?

Capri Holdings Limited CPRI looks inexpensive after a steep share-price decline, but the discount reflects a turnaround that is still short of a sustained revenue recovery. The stock trades at 6.87X

PayPal Cost Savings: Will $1.5B Plan Reshape Profitability?
PayPal Cost Savings: Will $1.5B Plan Reshape Profitability?

PayPal Holdings’ PYPL cost savings plan is taking center stage as the company works to improve profitability. It is on track to deliver at least $1.5 billion in gross run-rate savings over the next

Everspin Tech Targets $100M Revenue by 2029 With MRAM Expansion, Foundry PushPhoto, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
Everspin Tech Targets $100M Revenue by 2029 With MRAM Expansion, Foundry Push

Key Points

RenovoRx Eyes 2027 TIGeR-PaC Readout as RenovoCath Expands to 21 CentersPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
RenovoRx Eyes 2027 TIGeR-PaC Readout as RenovoCath Expands to 21 Centers

Key Points

Is First Trust Small Cap Growth AlphaDEX ETF (FYC) a Strong ETF Right Now?
Is First Trust Small Cap Growth AlphaDEX ETF (FYC) a Strong ETF Right Now?

Making its debut on 04/19/2011, smart beta exchange traded fund First Trust Small Cap Growth AlphaDEX ETF (FYC) provides investors broad exposure to the Style Box - Small Cap Growth category of the

Is First Trust Materials AlphaDEX ETF (FXZ) a Strong ETF Right Now?
Is First Trust Materials AlphaDEX ETF (FXZ) a Strong ETF Right Now?

Making its debut on 05/08/2007, smart beta exchange traded fund First Trust Materials AlphaDEX ETF (FXZ) provides investors broad exposure to the Materials ETFs category of the market.

What Are

Natera Supports Kupando Trial to Advance ctDNA Monitoring in CancerPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Natera Supports Kupando Trial to Advance ctDNA Monitoring in Cancer

Natera NTRA recently announced a collaboration with Kupando Therapeutics to support a Phase 1 clinical trial evaluating circulating tumor DNA (ctDNA) dynamics in patients with advanced skin cancers

PGY vs. UPST: Which AI Credit Stock Is the Better Investment Option?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/012f8213-0bd1-4831-98f2-6d5fae956d6a.png
PGY vs. UPST: Which AI Credit Stock Is the Better Investment Option?

The artificial intelligence (AI)-driven lending landscape has gained momentum as financial institutions increasingly turn to technology to improve credit underwriting, expand borrower access and

IonQ Q2 2026 Earnings Tomorrow: Time to Buy Stock, Wait or Sell?: https://staticx-tuner.zacks.com/images/articles/main/9b/170330.webp
IonQ Q2 2026 Earnings Tomorrow: Time to Buy Stock, Wait or Sell?

IonQ IONQ is scheduled to release its second-quarter 2026 results tomorrow, after market close, amid rapid strategic execution and expansion efforts. However, elevated valuation following the

Can MED's Trilivy Launch and Cost Cuts Drive a Q4 Profit Turnaround?
Can MED's Trilivy Launch and Cost Cuts Drive a Q4 Profit Turnaround?

Medifast, Inc. MED is entering a decisive phase of its turnaround as the Trilivy metabolic-health platform rolls out alongside another round of cost reductions. Management expects progress toward

Are Investors Undervaluing Teradata (TDC) Right Now?
Are Investors Undervaluing Teradata (TDC) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the

TransAct Technologies Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Convenience store, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/35bdb659-cf5a-466a-95a9-428a230a2d2e.png
TransAct Technologies Q2 Earnings Call Highlights

Key Points

Exploring Analyst Estimates for Toll Brothers (TOL) Q3 Earnings, Beyond Revenue and EPS
Exploring Analyst Estimates for Toll Brothers (TOL) Q3 Earnings, Beyond Revenue and EPS

Wall Street analysts forecast that Toll Brothers (TOL) will report quarterly earnings of $2.90 per share in its upcoming release, pointing to a year-over-year decline of 22.3%. It is anticipated

Why the Market Dipped But Veeva Systems (VEEV) Gained Today
Why the Market Dipped But Veeva Systems (VEEV) Gained Today

Veeva Systems (VEEV) closed at $217.80 in the latest trading session, marking a +2.01% move from the prior day. The stock's change was more than the S&P 500's daily loss of 0.18%. Elsewhere, the Dow

Samsara Inc. (IOT) Registers a Bigger Fall Than the Market: Important Facts to Note
Samsara Inc. (IOT) Registers a Bigger Fall Than the Market: Important Facts to Note

Samsara Inc. (IOT) closed at $38.22 in the latest trading session, marking a -1.32% move from the prior day. The stock's performance was behind the S&P 500's daily loss of 0.18%. Elsewhere, the Dow

ChargePoint Holdings, Inc. (CHPT) Sees a More Significant Dip Than Broader Market: Some Facts to Know
ChargePoint Holdings, Inc. (CHPT) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the latest close session, ChargePoint Holdings, Inc. (CHPT) was down 1.61% at $6.12. The stock fell short of the S&P 500, which registered a loss of 0.06% for the day. At the same time, the Dow

Cboe Global Stock Falls 22% in 3 Months: Time to Buy the Dip?
Cboe Global Stock Falls 22% in 3 Months: Time to Buy the Dip?

Shares of Cboe Global Markets CBOE have lost 22% in the past three months, underperforming the industry, the sector as well as the Zacks S&P 500 composite.  Cboe Global Markets is one of the largest

Okta (OKTA) Stock Falls Amid Market Uptick: What Investors Need to Know
Okta (OKTA) Stock Falls Amid Market Uptick: What Investors Need to Know

Okta (OKTA) closed at $147.30 in the latest trading session, marking a -2.02% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 0.26%. At the same time, the Dow

VirTra, Inc. (VTSI) Increases Yet Falls Behind Market: What Investors Need to Know
VirTra, Inc. (VTSI) Increases Yet Falls Behind Market: What Investors Need to Know

VirTra, Inc. (VTSI) closed at $3.11 in the latest trading session, marking a +1.63% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 1.79%. Elsewhere, the Dow